(Q38392346)

2 September 2017

title

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults (English)

1 reference

2 September 2017

1 reference

2

Kathryn M Edwards

1 reference

2 September 2017

4

Robert Belshe

1 reference

2 September 2017

9

Heather Hill

1 reference

2 September 2017

7

Diana L Noah

1 reference

2 September 2017

3

Cornelia L Dekker

1 reference

2 September 2017

1

David I Bernstein

1 reference

2 September 2017

Helen K B Talbot

5

1 reference

2 September 2017

Irene L Graham

series ordinal

6

1 reference

2 September 2017

Fenhua He

series ordinal

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Infectious Diseases

2 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 September 2017

volume

197

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

667-675

1 reference

Avian influenza A (H5N1) in 10 patients in Vietnam

2 September 2017

cites work

1 reference

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

21 January 2018

1 reference

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

21 January 2018

1 reference

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

21 January 2018

1 reference

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/527489

1 reference

2 September 2017

1 reference